Biosynthesis, assembly and secretion of coagulation factor VIII

Area of Science:

• Biochemistry
• Molecular Biology
• Genetics

Background:

• Factor VIII is a complex glycoprotein crucial for blood coagulation, deficient in hemophilia A.
• Factor VIII expression is significantly lower than Factor V due to post-transcriptional and post-translational processing inefficiencies.
• Proper folding and secretion of Factor VIII involve interactions with molecular chaperones in the endoplasmic reticulum.

Purpose of the Study:

• To investigate the molecular mechanisms limiting Factor VIII expression and secretion.
• To identify the roles of specific chaperones (BiP, calnexin, calreticulin) in Factor VIII processing.
• To explore potential strategies for enhancing Factor VIII secretion for therapeutic applications.

Main Methods:

• Analysis of Factor VIII domain organization and its impact on function.
• Investigation of Factor VIII interactions with endoplasmic reticulum chaperones (BiP, calnexin, calreticulin).
• Site-directed mutagenesis to assess the effect of specific binding sites on Factor VIII secretion efficiency.

Main Results:

• A potential BiP binding site mutation increased Factor VIII secretion threefold, suggesting modulation of chaperone interaction can enhance output.
• Factor VIII interacts with BiP, calnexin, and calreticulin, with calnexin/calreticulin interactions, particularly via the B domain's glycosylation, appearing essential for secretion.
• Copper ion binding in the A1 domain is proposed to stabilize heavy and light chain interaction.

Conclusions:

• Factor VIII secretion is critically dependent on interactions with calnexin and calreticulin, likely mediated by its glycosylated B domain.
• Modulating chaperone interactions, particularly with calnexin/calreticulin, offers a potential avenue for improving Factor VIII production.
• Understanding these secretion pathways has implications for developing effective somatic cell gene therapies for hemophilia A.